[French consensus on the care pathway for children with suspected or diagnosed type 1 obstructive sleep disorder].

Introduction: Obstructive sleep-disordered breathing (OSDB) is the consequence of an anatomical and/or functional reduction in upper airway size during sleep. Young patients can also be affected. TROS type 1 (TROS1 ) is most often found in young, non-obese children with no associated comorbidities, presenting with an otorhinolaryngological (ENT) obstacle, generally an enlargement of lymphoid tissue (tonsils and/or adenoids).

Objective: The aim of this article was to outline the consensus.

Materiel And Methods: A collaborative work, realized on the request of the French Society of Sleep Research and Medicine, to provide recommendations for the management of obstructive sleep apnea syndrome type 1 (OSA1 ) in children was published in 2023. This work brought together various experts in pediatric sleep disorders breathings (SDB). A sleep study for OSA1 is not mandatory when at least two nighttime symptoms are noted. A specialist otolaryngologist examination, including nasofibroscopy, is essential during diagnosis.

Discussion: The ENT specialist is the mainstay of initial care, but works as part of a multidisciplinary team that includes pediatricians, general practitioners, orthodontists and linguo-oro-maxillo-facial rehabilitation specialists.

Conclusion: Whatever the treatment, follow-up must be continuous and multidisciplinary; it is essential to ensure the effectiveness of the treatments implemented, the absence of SDB recurrence and the recovery of nasal breathing.